AMI ASSET MANAGEMENT CORP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 168 filers reported holding HAEMONETICS CORP in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AMI ASSET MANAGEMENT CORP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2016$13,162,000
+29.8%
376,283
+19.7%
0.90%
+28.3%
Q4 2015$10,137,000
+0.5%
314,428
+0.7%
0.70%
-8.7%
Q3 2015$10,091,000
-2.5%
312,215
+24.8%
0.77%
+0.1%
Q2 2015$10,345,000
-4.4%
250,129
+3.8%
0.77%
-8.6%
Q1 2015$10,823,000
+34.7%
240,934
+12.2%
0.84%
+19.9%
Q4 2014$8,036,000
+19.9%
214,748
+11.9%
0.70%
+6.8%
Q3 2014$6,704,000
+1.4%
191,983
+2.5%
0.66%0.0%
Q2 2014$6,609,000
+5.6%
187,344
-2.5%
0.66%
+2.5%
Q1 2014$6,261,000
+3.9%
192,115
+34.3%
0.64%
-3.3%
Q4 2013$6,025,000
+342.4%
143,018
+318.9%
0.66%
+238.3%
Q3 2013$1,362,00034,1400.20%
Other shareholders
HAEMONETICS CORP shareholders Q3 2014
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders